EU5 Infectious Diagnostics Market Outlook to 2024

Published : Dec-2017

No. of Pages : 764

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 11
2 Introduction 19
2.1 What Is This Report About? 19
2.2 Infectious Diagnostics Market Segmentation 19
2.3 Definitions of Markets Covered in the Report 21
3 Infectious Diagnostics Market, EU5 26
3.1 Infectious Diagnostics Market, EU5, Revenue ($m), 2010-2024 26
3.2 Infectious Diagnostics Market, EU5, Category Comparison by Revenue ($m), 2010-2024 28
3.3 Infectious Diagnostics Market, EU5, Revenue ($m), 2010-2017 30
3.4 Infectious Diagnostics Market, EU5, Revenue ($m), 2017-2024 33
3.5 Infectious Diagnostics Market, EU5, Volume (Units), 2010-2024 36
3.6 Infectious Diagnostics Market, EU5, Volume (Units), 2010-2017 38
3.7 Infectious Diagnostics Market, EU5, Volume (Units), 2017-2024 41
3.8 Infectious Diagnostics Market, EU5, Company Share by Revenue ($m), 2017 44
4 Infectious Diagnostics Market, France 46
4.1 Infectious Diagnostics Market, France, Revenue ($m), 2010-2017 46
4.2 Infectious Diagnostics Market, France, Revenue ($m), 2017-2024 49
4.3 Infectious Diagnostics Market, France, Volume (Units), 2010-2017 96
4.4 Infectious Diagnostics Market, France, Volume (Units), 2017-2024 99
4.5 Infectious Diagnostics Market, France, Average Price ($), 2010-2024 146
4.6 Infectious Diagnostics Market, France, Distribution Share by Revenue ($m), 2017 152
4.7 Infectious Diagnostics Market, France, Company Share by Revenue ($m), 2017 153
5 Infectious Diagnostics Market, Germany 155
5.1 Infectious Diagnostics Market, Germany, Revenue ($m), 2010-2017 155
5.2 Infectious Diagnostics Market, Germany, Revenue ($m), 2017-2024 158
5.3 Infectious Diagnostics Market, Germany, Volume (Units), 2010-2017 205
5.4 Infectious Diagnostics Market, Germany, Volume (Units), 2017-2024 208
5.5 Infectious Diagnostics Market, Germany, Average Price ($), 2010-2024 255
5.6 Infectious Diagnostics Market, Germany, Distribution Share by Revenue ($m), 2017 261
5.7 Infectious Diagnostics Market, Germany, Company Share by Revenue ($m), 2017 262
6 Infectious Diagnostics Market, Italy 264
6.1 Infectious Diagnostics Market, Italy, Revenue ($m), 2010-2017 264
6.2 Infectious Diagnostics Market, Italy, Revenue ($m), 2017-2024 267
6.3 Infectious Diagnostics Market, Italy, Volume (Units), 2010-2017 314
6.4 Infectious Diagnostics Market, Italy, Volume (Units), 2017-2024 317
6.5 Infectious Diagnostics Market, Italy, Average Price ($), 2010-2024 364
6.6 Infectious Diagnostics Market, Italy, Distribution Share by Revenue ($m), 2017 370
6.7 Infectious Diagnostics Market, Italy, Company Share by Revenue ($m), 2017 371
7 Infectious Diagnostics Market, Spain 373
7.1 Infectious Diagnostics Market, Spain, Revenue ($m), 2010-2017 373
7.2 Infectious Diagnostics Market, Spain, Revenue ($m), 2017-2024 376
7.3 Infectious Diagnostics Market, Spain, Volume (Units), 2010-2017 423
7.4 Infectious Diagnostics Market, Spain, Volume (Units), 2017-2024 426
7.5 Infectious Diagnostics Market, Spain, Average Price ($), 2010-2024 473
7.6 Infectious Diagnostics Market, Spain, Distribution Share by Revenue ($m), 2017 479
7.7 Infectious Diagnostics Market, Spain, Company Share by Revenue ($m), 2017 480
8 Infectious Diagnostics Market, United Kingdom 482
8.1 Infectious Diagnostics Market, United Kingdom, Revenue ($m), 2010-2017 482
8.2 Infectious Diagnostics Market, United Kingdom, Revenue ($m), 2017-2024 485
8.3 Infectious Diagnostics Market, United Kingdom, Volume (Units), 2010-2017 532
8.4 Infectious Diagnostics Market, United Kingdom, Volume (Units), 2017-2024 535
8.5 Infectious Diagnostics Market, United Kingdom, Average Price ($), 2010-2024 582
8.6 Infectious Diagnostics Market, United Kingdom, Distribution Share by Revenue ($m), 2017 588
8.7 Infectious Diagnostics Market, United Kingdom, Company Share by Revenue ($m), 2017 589
9 Overview of Key Companies in EU5 Infectious Diagnostics Market 591
9.1 Abbott Laboratories 591
9.2 F. Hoffmann-La Roche Ltd 591
9.3 Hologic Inc 591
9.4 Alere Inc 592
9.5 Siemens Healthcare GmbH 592
9.6 Qiagen NV 592
9.7 Beckman Coulter Inc 592
9.8 Bio-Rad Laboratories Inc 593
9.9 Cepheid 593
9.10 DiaSorin S.p.A 593
9.11 Thermo Fisher Scientific Inc 593
9.12 Becton Dickinson and Co 594
9.13 bioMerieux SA 594
10 Infectious Diagnostics Market Pipeline Products 595
11 Financial Deals Landscape 603
11.1 Debt Offerings 603
12 Recent Developments 604
12.1 Corporate Communications 604
12.2 Financial Announcements 618
12.3 Government and Public Interest 734
12.4 Legal And Regulatory 735
12.5 Other Significant Developments 736
12.6 Product News 743
12.7 Strategy And Business Planning 745
13 Appendix 748
13.1 Research Methodology 749
13.2 GlobalData Consulting 753
13.3 Contact Us 754
13.4 Disclaimer 754

1.1 List of Tables
Table 1: Infectious Diagnostics Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2010-2024 36
Table 2: Infectious Diagnostics Market, EU5, Category Comparison by Revenue ($m), USD Constant, 2010-2024 38
Table 3: Infectious Diagnostics Market, EU5, Revenue ($m), Historic, USD Constant, 2010-2017 40
Table 4: Infectious Diagnostics Market, EU5, Revenue ($m), Forecast, USD Constant, 2017-2024 43
Table 5: Infectious Diagnostics Market, EU5, Volume (Units), 2010-2024 46
Table 6: Infectious Diagnostics Market, EU5, Volume (Units), Historic, 2010-2017 48
Table 7: Infectious Diagnostics Market, EU5, Volume (Units), Forecast, 2017-2024 51
Table 8: Infectious Diagnostics Market, EU5, Company Share by Revenue ($m), USD Constant, 2017 54
Table 9: Infectious Diagnostics Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 56
Table 10: Infectious Diagnostics Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 59
Table 11: Chlamydia trichomatis Diagnostic Test Kits Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 62
Table 12: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 64
Table 13: Hepatitis Test Kits Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 66
Table 14: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 68
Table 15: Infectious Diagnostics Multiple Parameter Test Kits Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 70
Table 16: Infectious Diagnostics Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 72
Table 17: Mycobacterium tuberculosis Diagnostic Tests Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 74
Table 18: Polymerase Chain Reaction (PCR) Systems Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 76
Table 19: Post Streptococcus pyogenes Diagnostic Tests Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 78
Table 20: Retrovirus Tests Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 80
Table 21: Treponema pallidum Diagnostic Tests Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 82
Table 22: Chlamydia trichomatis Diagnostic Test Kits Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 84
Table 23: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 86
Table 24: Hepatitis Test Kits Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 88
Table 25: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 90
Table 26: Infectious Diagnostics Multiple Parameter Test Kits Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 92
Table 27: Infectious Diagnostics Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 94
Table 28: Mycobacterium tuberculosis Diagnostic Tests Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 96
Table 29: Polymerase Chain Reaction (PCR) Systems Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 98
Table 30: Post Streptococcus pyogenes Diagnostic Tests Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 100
Table 31: Retrovirus Tests Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 102
Table 32: Treponema pallidum Diagnostic Tests Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 104
Table 33: Infectious Diagnostics Market, France, Volume (Units), Historic, 2010-2017 106
Table 34: Infectious Diagnostics Market, France, Volume (Units), Forecast, 2017-2024 109
Table 35: Chlamydia trichomatis Diagnostic Test Kits Market, France, Volume (Units), Historic, 2010-2017 112
Table 36: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, France, Volume (Units), Historic, 2010-2017 114
Table 37: Hepatitis Test Kits Market, France, Volume (Units), Historic, 2010-2017 116
Table 38: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, France, Volume (Units), Historic, 2010-2017 118
Table 39: Infectious Diagnostics Multiple Parameter Test Kits Market, France, Volume (Units), Historic, 2010-2017 120
Table 40: Infectious Diagnostics Rapid Tests & POC Market, France, Volume (Units), Historic, 2010-2017 122
Table 41: Mycobacterium tuberculosis Diagnostic Tests Market, France, Volume (Units), Historic, 2010-2017 124
Table 42: Polymerase Chain Reaction (PCR) Systems Market, France, Volume (Units), Historic, 2010-2017 126
Table 43: Post Streptococcus pyogenes Diagnostic Tests Market, France, Volume (Units), Historic, 2010-2017 128
Table 44: Retrovirus Tests Market, France, Volume (Units), Historic, 2010-2017 130
Table 45: Treponema pallidum Diagnostic Tests Market, France, Volume (Units), Historic, 2010-2017 132
Table 46: Chlamydia trichomatis Diagnostic Test Kits Market, France, Volume (Units), Forecast, 2017-2024 134
Table 47: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, France, Volume (Units), Forecast, 2017-2024 136
Table 48: Hepatitis Test Kits Market, France, Volume (Units), Forecast, 2017-2024 138
Table 49: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, France, Volume (Units), Forecast, 2017-2024 140
Table 50: Infectious Diagnostics Multiple Parameter Test Kits Market, France, Volume (Units), Forecast, 2017-2024 142
Table 51: Infectious Diagnostics Rapid Tests & POC Market, France, Volume (Units), Forecast, 2017-2024 144
Table 52: Mycobacterium tuberculosis Diagnostic Tests Market, France, Volume (Units), Forecast, 2017-2024 146
Table 53: Polymerase Chain Reaction (PCR) Systems Market, France, Volume (Units), Forecast, 2017-2024 148
Table 54: Post Streptococcus pyogenes Diagnostic Tests Market, France, Volume (Units), Forecast, 2017-2024 150
Table 55: Retrovirus Tests Market, France, Volume (Units), Forecast, 2017-2024 152
Table 56: Treponema pallidum Diagnostic Tests Market, France, Volume (Units), Forecast, 2017-2024 154
Table 57: Infectious Diagnostics Market, France, Average Price ($) Historic, 2010-2017 155
Table 58: Infectious Diagnostics Market, France, Average Price ($), Forecast, 2017-2024 158
Table 59: Infectious Diagnostics Market, France, Distribution Share by Revenue ($m), USD Constant, 2017 161
Table 60: Infectious Diagnostics Market, France, Company Share by Revenue ($m), USD Constant, 2017 163
Table 61: Infectious Diagnostics Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 165
Table 62: Infectious Diagnostics Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 168
Table 63: Chlamydia trichomatis Diagnostic Test Kits Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 171
Table 64: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 173
Table 65: Hepatitis Test Kits Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 175
Table 66: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 177
Table 67: Infectious Diagnostics Multiple Parameter Test Kits Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 179
Table 68: Infectious Diagnostics Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 181
Table 69: Mycobacterium tuberculosis Diagnostic Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 183
Table 70: Polymerase Chain Reaction (PCR) Systems Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 185
Table 71: Post Streptococcus pyogenes Diagnostic Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 187
Table 72: Retrovirus Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 189
Table 73: Treponema pallidum Diagnostic Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 191
Table 74: Chlamydia trichomatis Diagnostic Test Kits Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 193
Table 75: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 195
Table 76: Hepatitis Test Kits Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 197
Table 77: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 199
Table 78: Infectious Diagnostics Multiple Parameter Test Kits Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 201
Table 79: Infectious Diagnostics Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 203
Table 80: Mycobacterium tuberculosis Diagnostic Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 205
Table 81: Polymerase Chain Reaction (PCR) Systems Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 207
Table 82: Post Streptococcus pyogenes Diagnostic Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 209
Table 83: Retrovirus Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 211
Table 84: Treponema pallidum Diagnostic Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 213
Table 85: Infectious Diagnostics Market, Germany, Volume (Units), Historic, 2010-2017 215
Table 86: Infectious Diagnostics Market, Germany, Volume (Units), Forecast, 2017-2024 218
Table 87: Chlamydia trichomatis Diagnostic Test Kits Market, Germany, Volume (Units), Historic, 2010-2017 221
Table 88: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Germany, Volume (Units), Historic, 2010-2017 223
Table 89: Hepatitis Test Kits Market, Germany, Volume (Units), Historic, 2010-2017 225
Table 90: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Germany, Volume (Units), Historic, 2010-2017 227
Table 91: Infectious Diagnostics Multiple Parameter Test Kits Market, Germany, Volume (Units), Historic, 2010-2017 229
Table 92: Infectious Diagnostics Rapid Tests & POC Market, Germany, Volume (Units), Historic, 2010-2017 231
Table 93: Mycobacterium tuberculosis Diagnostic Tests Market, Germany, Volume (Units), Historic, 2010-2017 233
Table 94: Polymerase Chain Reaction (PCR) Systems Market, Germany, Volume (Units), Historic, 2010-2017 235
Table 95: Post Streptococcus pyogenes Diagnostic Tests Market, Germany, Volume (Units), Historic, 2010-2017 237
Table 96: Retrovirus Tests Market, Germany, Volume (Units), Historic, 2010-2017 239
Table 97: Treponema pallidum Diagnostic Tests Market, Germany, Volume (Units), Historic, 2010-2017 241
Table 98: Chlamydia trichomatis Diagnostic Test Kits Market, Germany, Volume (Units), Forecast, 2017-2024 243
Table 99: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Germany, Volume (Units), Forecast, 2017-2024 245
Table 100: Hepatitis Test Kits Market, Germany, Volume (Units), Forecast, 2017-2024 247
Table 101: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Germany, Volume (Units), Forecast, 2017-2024 249
Table 102: Infectious Diagnostics Multiple Parameter Test Kits Market, Germany, Volume (Units), Forecast, 2017-2024 251
Table 103: Infectious Diagnostics Rapid Tests & POC Market, Germany, Volume (Units), Forecast, 2017-2024 253
Table 104: Mycobacterium tuberculosis Diagnostic Tests Market, Germany, Volume (Units), Forecast, 2017-2024 255
Table 105: Polymerase Chain Reaction (PCR) Systems Market, Germany, Volume (Units), Forecast, 2017-2024 257
Table 106: Post Streptococcus pyogenes Diagnostic Tests Market, Germany, Volume (Units), Forecast, 2017-2024 259
Table 107: Retrovirus Tests Market, Germany, Volume (Units), Forecast, 2017-2024 261
Table 108: Treponema pallidum Diagnostic Tests Market, Germany, Volume (Units), Forecast, 2017-2024 263
Table 109: Infectious Diagnostics Market, Germany, Average Price ($) Historic, 2010-2017 264
Table 110: Infectious Diagnostics Market, Germany, Average Price ($), Forecast, 2017-2024 267
Table 111: Infectious Diagnostics Market, Germany, Distribution Share by Revenue ($m), USD Constant, 2017 270
Table 112: Infectious Diagnostics Market, Germany, Company Share by Revenue ($m), USD Constant, 2017 272
Table 113: Infectious Diagnostics Market, Italy, Revenue ($m), USD Constant, Historic, 2010-2017 274
Table 114: Infectious Diagnostics Market, Italy, Revenue ($m), USD Constant, Forecast, 2017-2024 277

1.2 List of Figures
Figure 1: Infectious Diagnostics Market, Cross Country Comparison, EU5, Revenue ($m), USD Constant, 2010-2024 36
Figure 2: Infectious Diagnostics Market, EU5, Category Comparison by Revenue ($m), USD Constant, 2010-2024 38
Figure 3: Infectious Diagnostics Market, EU5, Revenue ($m), Historic, USD Constant, 2010-2017 40
Figure 4: Infectious Diagnostics Market, EU5, Revenue ($m), Forecast, USD Constant, 2017-2024 43
Figure 5: Infectious Diagnostics Market, EU5, Volume (Units), 2010-2024 46
Figure 6: Infectious Diagnostics Market, EU5, Volume (Units), Historic, 2010-2017 48
Figure 7: Infectious Diagnostics Market, EU5, Volume (Units), Forecast, 2017-2024 51
Figure 8: Infectious Diagnostics Market, EU5, Company Share (%) 2017 54
Figure 9: Infectious Diagnostics Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 56
Figure 10: Infectious Diagnostics Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 59
Figure 11: Chlamydia trichomatis Diagnostic Test Kits Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 62
Figure 12: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 64
Figure 13: Hepatitis Test Kits Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 66
Figure 14: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 68
Figure 15: Infectious Diagnostics Multiple Parameter Test Kits Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 70
Figure 16: Infectious Diagnostics Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 72
Figure 17: Mycobacterium tuberculosis Diagnostic Tests Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 74
Figure 18: Polymerase Chain Reaction (PCR) Systems Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 76
Figure 19: Post Streptococcus pyogenes Diagnostic Tests Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 78
Figure 20: Retrovirus Tests Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 80
Figure 21: Treponema pallidum Diagnostic Tests Market, France, Revenue ($m), USD Constant, Historic, 2010-2017 82
Figure 22: Chlamydia trichomatis Diagnostic Test Kits Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 84
Figure 23: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 86
Figure 24: Hepatitis Test Kits Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 88
Figure 25: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 90
Figure 26: Infectious Diagnostics Multiple Parameter Test Kits Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 92
Figure 27: Infectious Diagnostics Rapid Tests & POC Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 94
Figure 28: Mycobacterium tuberculosis Diagnostic Tests Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 96
Figure 29: Polymerase Chain Reaction (PCR) Systems Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 98
Figure 30: Post Streptococcus pyogenes Diagnostic Tests Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 100
Figure 31: Retrovirus Tests Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 102
Figure 32: Treponema pallidum Diagnostic Tests Market, France, Revenue ($m), USD Constant, Forecast, 2017-2024 104
Figure 33: Infectious Diagnostics Market, France, Volume (Units), Historic, 2010-2017 106
Figure 34: Infectious Diagnostics Market, France, Volume (Units), Forecast, 2017-2024 109
Figure 35: Chlamydia trichomatis Diagnostic Test Kits Market, France, Volume (Units), Historic, 2010-2017 112
Figure 36: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, France, Volume (Units), Historic, 2010-2017 114
Figure 37: Hepatitis Test Kits Market, France, Volume (Units), Historic, 2010-2017 116
Figure 38: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, France, Volume (Units), Historic, 2010-2017 118
Figure 39: Infectious Diagnostics Multiple Parameter Test Kits Market, France, Volume (Units), Historic, 2010-2017 120
Figure 40: Infectious Diagnostics Rapid Tests & POC Market, France, Volume (Units), Historic, 2010-2017 122
Figure 41: Mycobacterium tuberculosis Diagnostic Tests Market, France, Volume (Units), Historic, 2010-2017 124
Figure 42: Polymerase Chain Reaction (PCR) Systems Market, France, Volume (Units), Historic, 2010-2017 126
Figure 43: Post Streptococcus pyogenes Diagnostic Tests Market, France, Volume (Units), Historic, 2010-2017 128
Figure 44: Retrovirus Tests Market, France, Volume (Units), Historic, 2010-2017 130
Figure 45: Treponema pallidum Diagnostic Tests Market, France, Volume (Units), Historic, 2010-2017 132
Figure 46: Chlamydia trichomatis Diagnostic Test Kits Market, France, Volume (Units), Forecast, 2017-2024 134
Figure 47: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, France, Volume (Units), Forecast, 2017-2024 136
Figure 48: Hepatitis Test Kits Market, France, Volume (Units), Forecast, 2017-2024 138
Figure 49: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, France, Volume (Units), Forecast, 2017-2024 140
Figure 50: Infectious Diagnostics Multiple Parameter Test Kits Market, France, Volume (Units), Forecast, 2017-2024 142
Figure 51: Infectious Diagnostics Rapid Tests & POC Market, France, Volume (Units), Forecast, 2017-2024 144
Figure 52: Mycobacterium tuberculosis Diagnostic Tests Market, France, Volume (Units), Forecast, 2017-2024 146
Figure 53: Polymerase Chain Reaction (PCR) Systems Market, France, Volume (Units), Forecast, 2017-2024 148
Figure 54: Post Streptococcus pyogenes Diagnostic Tests Market, France, Volume (Units), Forecast, 2017-2024 150
Figure 55: Retrovirus Tests Market, France, Volume (Units), Forecast, 2017-2024 152
Figure 56: Treponema pallidum Diagnostic Tests Market, France, Volume (Units), Forecast, 2017-2024 154
Figure 57: Infectious Diagnostics Market, France, Company Share (%) 2017 163
Figure 58: Infectious Diagnostics Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 165
Figure 59: Infectious Diagnostics Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 168
Figure 60: Chlamydia trichomatis Diagnostic Test Kits Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 171
Figure 61: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 173
Figure 62: Hepatitis Test Kits Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 175
Figure 63: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 177
Figure 64: Infectious Diagnostics Multiple Parameter Test Kits Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 179
Figure 65: Infectious Diagnostics Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 181
Figure 66: Mycobacterium tuberculosis Diagnostic Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 183
Figure 67: Polymerase Chain Reaction (PCR) Systems Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 185
Figure 68: Post Streptococcus pyogenes Diagnostic Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 187
Figure 69: Retrovirus Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 189
Figure 70: Treponema pallidum Diagnostic Tests Market, Germany, Revenue ($m), USD Constant, Historic, 2010-2017 191
Figure 71: Chlamydia trichomatis Diagnostic Test Kits Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 193
Figure 72: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 195
Figure 73: Hepatitis Test Kits Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 197
Figure 74: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 199
Figure 75: Infectious Diagnostics Multiple Parameter Test Kits Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 201
Figure 76: Infectious Diagnostics Rapid Tests & POC Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 203
Figure 77: Mycobacterium tuberculosis Diagnostic Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 205
Figure 78: Polymerase Chain Reaction (PCR) Systems Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 207
Figure 79: Post Streptococcus pyogenes Diagnostic Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 209
Figure 80: Retrovirus Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 211
Figure 81: Treponema pallidum Diagnostic Tests Market, Germany, Revenue ($m), USD Constant, Forecast, 2017-2024 213
Figure 82: Infectious Diagnostics Market, Germany, Volume (Units), Historic, 2010-2017 215
Figure 83: Infectious Diagnostics Market, Germany, Volume (Units), Forecast, 2017-2024 218
Figure 84: Chlamydia trichomatis Diagnostic Test Kits Market, Germany, Volume (Units), Historic, 2010-2017 221
Figure 85: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Germany, Volume (Units), Historic, 2010-2017 223
Figure 86: Hepatitis Test Kits Market, Germany, Volume (Units), Historic, 2010-2017 225
Figure 87: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Germany, Volume (Units), Historic, 2010-2017 227
Figure 88: Infectious Diagnostics Multiple Parameter Test Kits Market, Germany, Volume (Units), Historic, 2010-2017 229
Figure 89: Infectious Diagnostics Rapid Tests & POC Market, Germany, Volume (Units), Historic, 2010-2017 231
Figure 90: Mycobacterium tuberculosis Diagnostic Tests Market, Germany, Volume (Units), Historic, 2010-2017 233
Figure 91: Polymerase Chain Reaction (PCR) Systems Market, Germany, Volume (Units), Historic, 2010-2017 235
Figure 92: Post Streptococcus pyogenes Diagnostic Tests Market, Germany, Volume (Units), Historic, 2010-2017 237
Figure 93: Retrovirus Tests Market, Germany, Volume (Units), Historic, 2010-2017 239
Figure 94: Treponema pallidum Diagnostic Tests Market, Germany, Volume (Units), Historic, 2010-2017 241
Figure 95: Chlamydia trichomatis Diagnostic Test Kits Market, Germany, Volume (Units), Forecast, 2017-2024 243
Figure 96: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Germany, Volume (Units), Forecast, 2017-2024 245
Figure 97: Hepatitis Test Kits Market, Germany, Volume (Units), Forecast, 2017-2024 247
Figure 98: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Germany, Volume (Units), Forecast, 2017-2024 249
Figure 99: Infectious Diagnostics Multiple Parameter Test Kits Market, Germany, Volume (Units), Forecast, 2017-2024 251
Figure 100: Infectious Diagnostics Rapid Tests & POC Market, Germany, Volume (Units), Forecast, 2017-2024 253
Figure 101: Mycobacterium tuberculosis Diagnostic Tests Market, Germany, Volume (Units), Forecast, 2017-2024 255
Figure 102: Polymerase Chain Reaction (PCR) Systems Market, Germany, Volume (Units), Forecast, 2017-2024 257
Figure 103: Post Streptococcus pyogenes Diagnostic Tests Market, Germany, Volume (Units), Forecast, 2017-2024 259
Figure 104: Retrovirus Tests Market, Germany, Volume (Units), Forecast, 2017-2024 261
Figure 105: Treponema pallidum Diagnostic Tests Market, Germany, Volume (Units), Forecast, 2017-2024 263
Figure 106: Infectious Diagnostics Market, Germany, Company Share (%) 2017 272
Figure 107: Infectious Diagnostics Market, Italy, Revenue ($m), USD Constant, Historic, 2010-2017 274
Figure 108: Infectious Diagnostics Market, Italy, Revenue ($m), USD Constant, Forecast, 2017-2024 277
Figure 109: Chlamydia trichomatis Diagnostic Test Kits Market, Italy, Revenue ($m), USD Constant, Historic, 2010-2017 280
Figure 110: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Italy, Revenue ($m), USD Constant, Historic, 2010-2017 282
Figure 111: Hepatitis Test Kits Market, Italy, Revenue ($m), USD Constant, Historic, 2010-2017 284
Figure 112: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Italy, Revenue ($m), USD Constant, Historic, 2010-2017 286
Figure 113: Infectious Diagnostics Multiple Parameter Test Kits Market, Italy, Revenue ($m), USD Constant, Historic, 2010-2017 288
Figure 114: Infectious Diagnostics Rapid Tests & POC Market, Italy, Revenue ($m), USD Constant, Historic, 2010-2017 290
Figure 115: Mycobacterium tuberculosis Diagnostic Tests Market, Italy, Revenue ($m), USD Constant, Historic, 2010-2017 292
Figure 116: Polymerase Chain Reaction (PCR) Systems Market, Italy, Revenue ($m), USD Constant, Historic, 2010-2017 294
Figure 117: Post Streptococcus pyogenes Diagnostic Tests Market, Italy, Revenue ($m), USD Constant, Historic, 2010-2017 296
Figure 118: Retrovirus Tests Market, Italy, Revenue ($m), USD Constant, Historic, 2010-2017 298
Figure 119: Treponema pallidum Diagnostic Tests Market, Italy, Revenue ($m), USD Constant, Historic, 2010-2017 300
Figure 120: Chlamydia trichomatis Diagnostic Test Kits Market, Italy, Revenue ($m), USD Constant, Forecast, 2017-2024 302
Figure 121: Cytomegalovirus (CMV) & Herpes simplex Virus (HSV) Tests Market, Italy, Revenue ($m), USD Constant, Forecast, 2017-2024 304
Figure 122: Hepatitis Test Kits Market, Italy, Revenue ($m), USD Constant, Forecast, 2017-2024 306
Figure 123: Human Papilloma Virus (HPV) & Epstein-Barr Virus (EBV) Tests Market, Italy, Revenue ($m), USD Constant, Forecast, 2017-2024 308
Figure 124: Infectious Diagnostics Multiple Parameter Test Kits Market, Italy, Revenue ($m), USD Constant, Forecast, 2017-2024 310
Figure 125: Infectious Diagnostics Rapid Tests & POC Market, Italy, Revenue ($m), USD Constant, Forecast, 2017-2024 312
Figure 126: Mycobacterium tuberculosis Diagnostic Tests Market, Italy, Revenue ($m), USD Constant, Forecast, 2017-2024 314
Figure 127: Polymerase Chain Reaction (PCR) Systems Market, Italy, Revenue ($m), USD Constant, Forecast, 2017-2024 316
Figure 128: Post Streptococcus pyogenes Diagnostic Tests Market, Italy, Revenue ($m), USD Constant, Forecast, 2017-2024 318

Filed in: In Vitro Diagnostic, Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026 “The global in vitro fertilization market size is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1 % during the forecast period” The global in vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026. The key factors fueling the growth of this market include an increase in the median age of first-time mothers, declining fertility rates, rising male infertility, rise in obesity rate and growing consumption of alcohol, and growing awareness about the availability of treatment options. However, the high cost and low success rate of IVF treatment and restrictive regulations and ethical concerns are expected to restrict the growth of the IVF market to a certain e......	$4950
Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact) Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) Summary Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area. The model discusses in detail the impact of COVID-19 on Assisted Reproductive Technology Devices market for the year 2020 and beyond. Assisted Reproductive Technology (ART) refers to reproductive health procedures that treat infertile women to achieve pregnancy. For decades now across much of the developed world, several techniques of ART have been in use with varying pregnancy success rates. These techniques primarily include, but are no......	$7500
Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact) Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) Summary Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Multiparameter CT/NG NAAT Tests market for the year 2020 and beyond. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic preg......	$7500
Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028 Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028 Summary Hemophilia A and B are rare, genetic, X-linked deficiencies in the blood clotting factors VIII (FVIII) and IX (FIX), respectively. Patients can be categorized as mild, moderate or severe depending on the percentage of circulating FVIII or FIX in their blood. Patients can be treated either on-demand or prophylactically using plasma-derived or recombinant replacement factors, the current standard of care. Although these therapies are effective, they are associated with a great treatment burden. There is a significant unmet need for new therapies that can reduce the great treatment burden associated with intravenous administration, the frequency of prophylactic infusions, and the risk of developing neutralizing a......	$10995
Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Human Immunodeficiency Virus (HIV) has become one of the world's most serious health issues affecting approximately 36.9 million people. The epidemiology of HIV infections varies from one geographical region to another. Sources indicate that in many countries, incidence rates for HIV have stabilized due to the campaigns that provide condoms, pre-exposure prophylaxis, sterile needles, syringes, antiretroviral therapy (ART), and prevention of mother-to-child transmission interv......	$7500
Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia trachomatis. Patient access to Chlamydia screening, and thus the number of reported cases, varies substantially between countries. In some countries annual screening is recommended for specific patient groups deemed to be at higher risk of contracting the disease, such as sexually active females younger than 25 years. Additionally, screening of pregnant women for Chlamydia Trachomatis infections is currently recomme......	$7500
EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Globally, lung cancer is the second most common cancer in men and the third most common cancer in women. There are two main types of lung cancer; small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), with NSCLC accounting for approximately 80-90% of all lung cancer cases. The 5-year survival rate for patients with stage IV disease is less than 5% as majority of patients present with the advanced or metastatic disease at diagnosis. EGFR is a member of the receptor tyrosine kinase family and a major factor in regulating ......	$7500
Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cervical cancer screening has traditionally been based on cervical cytology. In recent years however, many countries have incorporated Human Papilloma Virus (HPV) tests into their cervical cancer and pre-cancer screening programs. Cytology based screening programs require a well-established healthcare infrastructure for processing and interpretation of samples. It is hoped that HPV screening methods may enable better prevention of these disease, these devices are also highly sensitive an......	$7500
Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model "Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cytomegalovirus (CMV) represents the most common congenital, viral infection in the developed world and awareness of this disease is increasing. Few countries have official guidelines in place for CMV screening but in general testing tends to be performed for sperm donations, immunocompromised cases, and pregnant women. Diagnosis of CMV infections is complex as symptoms are often non-specific and mimic mononucleosis or the flu. Approximately 21-25% of primary CMV infections are symptomatic ......	$7500
Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Prenatal Screening (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Prenatal Screening is now routinely used in developed countries for early detection of fetal abnormalities. Various biochemical analytes are measured during the first or second trimester including free-beta human chorionic gonadotropin (hCG), total hCG, pregnancy associated plasma protein-A (PAPP-A), Alpha-fetoprotein (AFP), unconjugated estriol (uE3), and Inhibin A. These markers are used to screen for Down syndrome (Trisomy 21) as well as Edwards syndrome (Trisomy 18) and ectopic pregnancy. Additionally, maternal s......	$7500

EU5 Infectious Diagnostics Market Outlook to 2024

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026

Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact)

Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028

Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Prenatal Screening (In Vitro Diagnostics) – Global Market Analysis and Forecast Model